FMR LLC 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 18,678,526 9.113% | -3,760,598 (-16.76%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 22,439,124 12.002% | -5,534,422 (-19.78%) | Filing |
| 2023-09-11 08:23 am Purchase | 2023-09-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 27,973,546 14.962% | 24,768,624 (+772.83%) | Filing |
| 2023-02-09 12:39 pm Sale | 2023-02-09 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 3,204,922 5.132% | -69,635 (-2.13%) | Filing |
| 2022-11-10 11:55 am Sale | 2022-11-09 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 3,274,557 5.951% | -1,005,937 (-23.50%) | Filing |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 4,280,494 11.125% | -1,383,721 (-24.43%) | Filing |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 5,664,215 14.999% | 1,456,641 (+34.62%) | Filing |
| 2020-10-13 10:35 am Purchase | 2020-10-12 | 13G | Taysha Gene Therapies, Inc. TSHA | FMR LLC | 4,207,574 11.374% | 4,207,574 (New Position) | Filing |